Lung Cancer Stage 4 Doctors Abroad — Page 2

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

The doctor graduated from Ankara University Medical School and completed residency training in internal medicine at Ankara GATA Medical School. Specializing in medical oncology and hematology, the doctor completed a clinical fellowship in the USA. A pioneer in Turkey, the doctor was part of the team that performed the first bone marrow transplantation in the country. The doctor has served as a visiting lecturer at prestigious institutions in London and Switzerland. Holding the European Medical Oncology Certificate, the doctor is a founding member of both The Turkish Society of Medical Oncology and the Turkish Oncology Group. The clinical focus includes breast, gastrointestinal, lung cancers, lymphomas, and myeloma.

Dr. Saban Sec is a medical oncologist with experience at leading hospitals, including Haseki Training and Research Hospital, Prof. Dr. Cemil Taşcıoğlu City Hospital, and Bahçelievler Medikalpark Hospital. He currently represents specialist physicians in the Turkish Medical Oncology Association. He is also a member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association.

Dr. Sec treats breast, lung, gastrointestinal, prostate, urogenital, head and neck cancers, as well as sarcomas and rare tumors. He has published many peer-reviewed articles on cancer prognosis, treatment outcomes, and survival rates. His research includes studies with large patient groups, such as 138 patients with HER2-positive metastatic gastric cancer. Dr. Sec focuses on prognostic factors and treatment responses in different cancers. He is dedicated to improving cancer care.

Professor Ozcan Yildiz is a leading medical oncologist at Medipol Mega University Hospital who specialises in managing complex malignancies, including small cell lung cancer.

• Specialises in systemic therapy for advanced lung cancer cases to slow disease progression and manage symptoms
• Published research on rare presentations of lung cancer to improve diagnostic accuracy for better patient outcomes
• Member of the Turkish Society of Medical Oncology, staying current with international treatment protocols
• Experienced in treating neuroendocrine tumours through targeted medical oncology approaches

Associate Professor Tahsin Ozatli is a specialist oncologist at Istinye University Liv Hospital with a focus on advanced-stage lung and gastrointestinal cancers.

• Promoted to Associate Professor for his academic contributions to medical oncology
• Trained at the Ankara Oncology Clinic, a premier centre for cancer research and care in Turkey
• Specialises in treating patients with metastatic lung cancer using systemic therapies
• Experienced in managing complex cases within regional training and research hospitals

Associate Professor Yusuf Acikgoz recently sharpened his oncology expertise at Ohio State University – one of the leading cancer research centres in the United States.

• Specialises in immunotherapy and novel drug treatments for advanced lung cancer
• Served as assistant investigator for global Phase III clinical trials
• Completed immuno-oncology training through the Central European Cooperative Oncology Group
• Member of the American Society of Clinical Oncology (ASCO)
• Practises at Lokman Hekim University – a top-tier Turkish teaching hospital

Professor Cemil Bilir is a specialist medical oncologist at VM Medical Park Pendik with extensive international training from the Cleveland Clinic.

• Completed a research fellowship at Northeastern University in Boston focusing on biotechnology and nanomedicine
• Focuses on advanced-stage cancer management using evidence-based protocols from the latest clinical research
• Maintains active membership in the American Society of Clinical Oncology (ASCO)
• Holds a PhD in Inorganic Chemistry, providing deep insight into how chemotherapy and targeted drugs work
• Serves as a Professor at Sakarya University Faculty of Medicine training future oncologists

Professor Gul Alco is a leading radiation oncologist at Medipol Acibadem District Hospital with high-level academic expertise in managing complex malignancies.

• Holds the rank of Professor at Istanbul Medipol University School of Medicine
• Specialises in radiation oncology for treating advanced-stage tumours
• Trained at Istanbul University, one of Turkey's oldest and most prestigious medical schools
• Focuses on precision radiotherapy to target cancer cells while sparing healthy tissue
• Member of key professional bodies dedicated to oncology and radiation research

Associate Professor Nail Paksoy is a highly regarded medical oncologist specializing in advanced lung cancer treatments at Medipol Bahçelievler University Hospital.

• Holds ESMO Board Certification in Medical Oncology, a prestigious European mark of clinical excellence
• Served as a sub-investigator for Pfizer in global trials comparing Lorlatinib to Crizotinib for NSCLC
• Developed published research on identifying mutation markers to improve lung cancer drug effectiveness
• Expertise in immunotherapy and targeted agents like Osimertinib and Alectinib for metastatic cases
• Previously practiced at the Istanbul University Oncology Institute, a major hub for complex cancer care

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Ozden is a dual-certified specialist in internal medicine and oncology at VM Medical Park Pendik Hospital. He trained at Istanbul University's prestigious English Medical Program.

• Specialises in managing advanced-stage malignancies using systemic therapies
• Focuses on precision medicine for stage 4 respiratory cases
• Completed oncology subspecialty training at Kocaeli University's Faculty of Medicine
• Expert in coordinating multidisciplinary care for complex oncological needs